Monica Civallero
University of Modena and Reggio Emilia(IT)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, T-cell and Retrovirus Studies, Chronic Lymphocytic Leukemia Research, Histone Deacetylase Inhibitors Research, CAR-T cell therapy research
Most-Cited Works
- → Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project(2020)134 cited
- → Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project(2021)119 cited
- → Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas(2019)63 cited
- → Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine(2017)49 cited
- → ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project(2021)44 cited
- → The oral protein-kinase Cβinhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines(2008)35 cited
- → The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines(2016)35 cited
- Cytochemical demonstration of nitric oxide synthase and 5' nucleotidase in human glioblastoma.(1997)
- → Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases(2017)20 cited
- → Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination(2020)20 cited